Alzheimer's disease

Researchers identified a previously overlooked mechanism of brain cell death linked to Alzheimer's disease and frontotemporal dementia. This discovery could lead to new treatments aimed at slowing neuron loss by interrupting the process before cells are destroyed.

Danny Glover has been diagnosed with Alzheimer's disease and has been battling it for several years, as revealed by him and his family.

Danny Glover, 79, a star of Lethal Weapon, has disclosed his Alzheimer's disease diagnosis. The announcement highlights his personal health challenge.

Lethal Weapon star Danny Glover, 79, has revealed he has been diagnosed with Alzheimer's disease. The announcement was made through a public statement.

Scientists may have discovered that a common brain protein facilitates the spread of Alzheimer's by transporting toxic Tau proteins from damaged neurons to healthy ones. Blocking these proteins could potentially slow the disease's progression.

Medical evidence suggests a healthy lifestyle can prevent Alzheimer's disease or dementia. The article highlights the role of lifestyle in reducing the risk of these conditions.

A new study challenges the belief that omega-3 supplements help prevent Alzheimer's, finding no cognitive benefits in older adults at risk despite increased blood levels of omega-3 fatty acids. The study suggests relying on lifestyle habits like exercise, diet, and sleep rather than supplements alone for brain health.

New York Congressman Mike Lawler spoke from the House floor about Eyewitness News anchor Bill Ritter's brave revelation that he is fighting Alzheimer's disease.

Jessica C. Guthrie quit her job as vice president of a nonprofit to care for her mother, who was diagnosed with early-onset Alzheimer's at 65. The care would have cost $10,000 a month, and Guthrie now provides 24/7 care despite financial struggles.

New research identifies hearing loss as a potential warning sign for Alzheimer's disease. The number of Alzheimer's cases is projected to double by 2060, prompting studies on risk factors linked to cognitive decline.

New research suggests hearing loss may be a warning sign for Alzheimer's disease. The number of Alzheimer's cases is projected to double by 2060, with studies identifying potential risk factors linked to cognitive decline.

The number of people with Alzheimer's disease is projected to double by 2060. New research identifies hearing loss and other risk factors as potential early warning signs of cognitive decline.

A Zumba class in Richmond, titled the Zumba Purple Party, is promoting community engagement while raising awareness for Alzheimer's disease.

Nearly 1 in 4 U.S. adults serve as caregivers for relatives with complex medical needs, with 63 million Americans providing care in 2025—a 20 million increase since 2015. Family caregivers, often unpaid, spend an average of 27 hours weekly managing care for loved ones with chronic conditions, facing significant financial and emotional strain.

Nearly 1 in 4 U.S. adults serve as caregivers for relatives with complex medical needs, with 63 million Americans currently in caregiving roles. The National Alliance for Caregiving reports a 20 million increase since 2015, driven by aging populations and chronic health conditions, while caregivers face significant emotional and financial strain.

Bill Ritter, a veteran New York news anchor, announced his early-stage Alzheimer's diagnosis during his final Eyewitness News broadcast, ending his 20-year tenure at WABC-TV. He will continue working with the station in a new role focused on reporting about Alzheimer's and neurological conditions.

A new study claims that low blood pressure triples the risk of developing Alzheimer's disease. The research highlights a potential link between cardiovascular health and neurodegenerative conditions.

A Japanese American woman with advanced Alzheimer's disease showed significant improvements in speech, mobility, and memory after taking psilocybin-containing mushrooms in a case study published in Frontiers in Neuroscience. The study notes limitations due to being a single-patient case without controls or long-term follow-up.

ETH Zurich University molecular pharmacologists developed a compound called Compound-10 that slows Alzheimer's progression. The drug, researched for 20 years, showed increased survival in lab studies.

Jon Snow, a former Channel 4 News presenter, has been living with Alzheimer's disease. He attended the National Portrait Gallery Re-Opening in London on June 20, 2023.

Researchers have identified two breakthroughs in diagnosing Alzheimer's disease years before severe symptoms appear, involving advancements in blood tests and brain scans. These developments offer potential for earlier intervention and improved patient outcomes.

New research has identified subtle signs of Alzheimer's disease that may appear as early as age 45, up to two decades before a typical diagnosis. These early indicators could help in the early detection and management of the condition.

The article discusses a patient's experience where initial mood swings were misdiagnosed as depression, leading to a later Alzheimer's diagnosis and subsequent neglect, highlighting systemic failures in Alzheimer's care.

Retro Biosciences, a longevity startup backed by OpenAI CEO Sam Altman, has raised funding at a $1.8 billion valuation. The company aims to add 10 healthy years to human lifespan through gene therapies and cell replacement therapies. The company is currently running its first clinical trial for an Alzheimer's disease treatment, with positive results and data expected around August.

Newt Gingrich argues that Congress must increase funding and support for Alzheimer's research to combat the disease affecting 7.2 million Americans. Recent breakthroughs have identified amyloid proteins as a cause and developed blood tests for early detection, but healthcare policy barriers prevent wider access to these diagnostics and treatments.

A Chinese military research team from Army Medical University found that omega-3 fish oil supplements may not improve cognition and could potentially accelerate cognitive decline in Alzheimer's disease patients. China's northeastern region has made a significant discovery of rare-earth elements, addressing a prior scarcity in the area.

A new study by UC San Diego found that women may be more sensitive to common dementia risk factors, increasing their risk of Alzheimer's disease. The study involved over 17,000 adults and suggests tailoring prevention strategies for women could reduce Alzheimer's risk. This discovery could lead to more targeted approaches in preventing the disease.

Researchers have identified a new enzyme called IDOL that contributes to Alzheimer's disease, and removing it from neurons improves brain processes and reduces amyloid plaques. This discovery may lead to future treatments that protect the brain from decline. The findings could potentially help develop new therapies beyond current treatments.

The lifetime cost of care for someone with Alzheimer's disease is over $400,000, which will become a growing concern as the population ages. Preparation for this expense is necessary. The cost includes various aspects of care.

Researchers have shown that malfunctioning mitochondria may cause cognitive decline in neurodegenerative diseases. Scientists created a new tool to boost mitochondrial activity, restoring memory performance in mouse models of dementia. This discovery could offer a new target for future Alzheimer's treatments.

A recent Joe Rogan podcast episode has led to a surge in demand for alternative cancer treatments. The episode sparked interest in unconventional methods for combating cancer. Experts note that while some alternative treatments may be promising, others lack scientific evidence.

Biogen is advancing its Alzheimer's drug to a late-stage trial despite disappointing data, with signals suggesting the treatment decreases levels of tau and slows cognitive decline. The treatment appears to be most effective at the lowest dose. This development is a significant step in the search for an effective Alzheimer's treatment.

Biogen reported mixed results from a clinical trial for an Alzheimer's disease treatment, while Takeda Pharmaceutical plans to cut about 4,500 jobs as part of a restructuring effort. The Biogen drug, diranersen, reduced levels of tau in patients with early-stage Alzheimer's and slowed cognitive decline. Takeda expects annual savings of over $1.27 billion by fiscal 2028.

Biogen's tau-targeting Alzheimer's drug diranersen showed mixed results in a mid-stage clinical trial, reducing tau levels and slowing cognitive decline, but failed to achieve its primary efficacy goal. The study investigated three escalating dosing regimens, with the lowest dose showing the best results. Biogen reported that tau reductions correlated to a slowing of cognitive decline.

Drinking two to three cups of coffee a day may lower dementia risk by 35%. Researchers found that moderate coffee intake was linked to a lower risk of dementia, especially before age 75. Caffeine may help keep brain cells active and reduce inflammation associated with Alzheimer’s disease.

The FDA has approved the expanded use of Auvelity for treating agitation in Alzheimer's disease patients. Auvelity was originally approved for major depressive disorder and has shown efficacy in two randomized trials. The approval represents a significant advancement in treating complications of Alzheimer's disease.

A major Cochrane review found that amyloid-targeting Alzheimer's drugs have little to no effect on memory decline and dementia severity. The review analyzed results from 17 clinical trials involving over 20,000 participants. Researchers concluded that lowering amyloid-beta alone is unlikely to produce meaningful clinical gains.

A hantavirus outbreak occurred on a cruise ship, highlighting key moments in the deadly crisis. The virus spread among passengers, and experts are studying its footprint in the US. The outbreak has led to discussions about health and wellness, including the importance of exercise and diet.

A study by researchers at Loma Linda University found a link between a nutrient-rich food and reduced risk of Alzheimer's disease in older adults. The study suggests that consuming this food fairly frequently could lower the risk. This discovery may have implications for prevention and treatment of Alzheimer's.

A new study from Loma Linda University found that eating eggs can reduce the risk of Alzheimer's disease by up to 27%. The research analyzed data from nearly 40,000 US adults over 65 years old and concluded that moderate egg consumption was associated with a lower risk of Alzheimer's. Egg intake was divided into visible and hidden eggs, with those consuming eggs five or more times per week having the lowest risk.